Annual CFI
$44.18 M
+$220.92 M+125.00%
December 31, 2024
Summary
- As of March 12, 2025, PTCT annual cash flow from investing activities is $44.18 million, with the most recent change of +$220.92 million (+125.00%) on December 31, 2024.
- During the last 3 years, PTCT annual CFI has fallen by -$175.00 million (-79.84%).
- PTCT annual CFI is now -84.77% below its all-time high of $290.18 million, reached on December 31, 2022.
Performance
PTCT Cash From Investing Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly CFI
$267.71 M
+$310.39 M+727.33%
December 31, 2024
Summary
- As of March 12, 2025, PTCT quarterly cash flow from investing activities is $267.71 million, with the most recent change of +$310.39 million (+727.33%) on December 31, 2024.
- Over the past year, PTCT quarterly CFI has increased by +$382.64 million (+332.93%).
- PTCT quarterly CFI is now at all-time high.
Performance
PTCT Quarterly CFI Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
TTM CFI
$44.18 M
+$362.13 M+113.90%
December 31, 2024
Summary
- As of March 12, 2025, PTCT TTM cash flow from investing activities is $44.18 million, with the most recent change of +$362.13 million (+113.90%) on December 31, 2024.
- Over the past year, PTCT TTM CFI has increased by +$306.88 million (+116.82%).
- PTCT TTM CFI is now -86.45% below its all-time high of $326.02 million, reached on September 30, 2022.
Performance
PTCT TTM CFI Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Cash From Investing Formula
CFI = Cash Inflows from Investments − Cash Outflows for Investments
PTCT Cash From Investing Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | +125.0% | +332.9% | +116.8% |
| 3 y3 years | -79.8% | +1004.5% | +188.6% |
| 5 y5 years | +111.4% | +1004.5% | +188.6% |
PTCT Cash From Investing Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3-year | -84.8% | +125.0% | at high | +332.9% | -86.5% | +113.9% |
| 5 y | 5-year | -84.8% | +107.9% | at high | +167.9% | -86.5% | +107.6% |
| alltime | all time | -84.8% | +107.9% | at high | +167.9% | -86.5% | +107.6% |
PTC Therapeutics Cash From Investing History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Dec 2024 | $44.18 M(-125.0%) | $267.71 M(-727.3%) | $44.18 M(-113.9%) |
| Sep 2024 | - | -$42.67 M(-35.3%) | -$317.95 M(+4.3%) |
| Jun 2024 | - | -$65.92 M(-42.6%) | -$304.87 M(+16.1%) |
| Mar 2024 | - | -$114.93 M(+21.7%) | -$262.70 M(+48.6%) |
| Dec 2023 | -$176.74 M(-160.9%) | -$94.42 M(+219.0%) | -$176.74 M(+254.3%) |
| Sep 2023 | - | -$29.60 M(+24.6%) | -$49.88 M(-142.9%) |
| Jun 2023 | - | -$23.75 M(-18.0%) | $116.16 M(-45.3%) |
| Mar 2023 | - | -$28.97 M(-189.3%) | $212.17 M(-26.9%) |
| Dec 2022 | $290.18 M(+32.4%) | $32.44 M(-76.2%) | $290.18 M(-11.0%) |
| Sep 2022 | - | $136.44 M(+88.8%) | $326.02 M(+28.2%) |
| Jun 2022 | - | $72.25 M(+47.3%) | $254.28 M(+6.8%) |
| Mar 2022 | - | $49.04 M(-28.2%) | $238.08 M(+8.6%) |
| Dec 2021 | $219.18 M(-139.0%) | $68.27 M(+5.5%) | $219.18 M(-483.1%) |
| Sep 2021 | - | $64.70 M(+15.4%) | -$57.21 M(-88.9%) |
| Jun 2021 | - | $56.06 M(+85.9%) | -$516.13 M(+20.0%) |
| Mar 2021 | - | $30.15 M(-114.5%) | -$430.13 M(-23.4%) |
| Dec 2020 | -$561.55 M(+45.0%) | -$208.12 M(-47.2%) | -$561.55 M(-3.6%) |
| Sep 2020 | - | -$394.21 M(-377.5%) | -$582.42 M(+269.1%) |
| Jun 2020 | - | $142.06 M(-240.3%) | -$157.78 M(-53.3%) |
| Mar 2020 | - | -$101.27 M(-55.8%) | -$338.01 M(-12.7%) |
| Dec 2019 | -$387.24 M(+808.7%) | -$229.00 M(-852.6%) | -$387.24 M(+111.8%) |
| Sep 2019 | - | $30.43 M(-179.7%) | -$182.84 M(-23.0%) |
| Jun 2019 | - | -$38.17 M(-74.6%) | -$237.38 M(+24.0%) |
| Mar 2019 | - | -$150.50 M(+511.9%) | -$191.46 M(+349.3%) |
| Dec 2018 | -$42.61 M | -$24.60 M(+2.0%) | -$42.61 M(-40.9%) |
| Sep 2018 | - | -$24.11 M(-411.4%) | -$72.06 M(+151.3%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Jun 2018 | - | $7.74 M(-569.9%) | -$28.67 M(+121.4%) |
| Mar 2018 | - | -$1.65 M(-97.0%) | -$12.95 M(-198.7%) |
| Dec 2017 | $13.12 M(-87.4%) | -$54.04 M(-380.4%) | $13.12 M(-85.5%) |
| Sep 2017 | - | $19.27 M(-17.9%) | $90.29 M(-17.4%) |
| Jun 2017 | - | $23.47 M(-3.9%) | $109.25 M(+2.3%) |
| Mar 2017 | - | $24.42 M(+5.6%) | $106.78 M(+2.2%) |
| Dec 2016 | $104.48 M(-602.0%) | $23.13 M(-39.5%) | $104.48 M(+253.9%) |
| Sep 2016 | - | $38.24 M(+82.1%) | $29.52 M(-296.8%) |
| Jun 2016 | - | $21.00 M(-5.1%) | -$15.00 M(-22.3%) |
| Mar 2016 | - | $22.12 M(-142.7%) | -$19.30 M(-7.3%) |
| Dec 2015 | -$20.81 M(-85.7%) | -$51.83 M(+724.8%) | -$20.81 M(-74.7%) |
| Sep 2015 | - | -$6.28 M(-137.6%) | -$82.17 M(+198.7%) |
| Jun 2015 | - | $16.70 M(-19.0%) | -$27.50 M(-77.1%) |
| Mar 2015 | - | $20.61 M(-118.2%) | -$120.29 M(-17.1%) |
| Dec 2014 | -$145.17 M(+13.6%) | -$113.19 M(-334.0%) | -$145.17 M(+455.9%) |
| Sep 2014 | - | $48.38 M(-163.6%) | -$26.11 M(-86.7%) |
| Jun 2014 | - | -$76.09 M(+1683.3%) | -$196.51 M(+48.8%) |
| Mar 2014 | - | -$4.27 M(-172.7%) | -$132.07 M(+3.3%) |
| Dec 2013 | -$127.83 M(>+9900.0%) | $5.87 M(-104.8%) | -$127.83 M(-4.4%) |
| Sep 2013 | - | -$122.02 M(+946.5%) | -$133.70 M(+1043.8%) |
| Jun 2013 | - | -$11.66 M(>+9900.0%) | -$11.69 M(>+9900.0%) |
| Mar 2013 | - | -$21.00 K(+281.8%) | -$51.60 K(-72.7%) |
| Dec 2012 | -$189.00 K(-100.7%) | -$5500.00(+27.9%) | -$189.00 K(+3.0%) |
| Sep 2012 | - | -$4300.00(-79.3%) | -$183.50 K(+2.4%) |
| Jun 2012 | - | -$20.80 K(-86.9%) | -$179.20 K(+13.1%) |
| Mar 2012 | - | -$158.40 K | -$158.40 K |
| Dec 2011 | $27.70 M | - | - |
FAQ
- What is PTC Therapeutics annual cash flow from investing activities?
- What is the all time high annual CFI for PTC Therapeutics?
- What is PTC Therapeutics annual CFI year-on-year change?
- What is PTC Therapeutics quarterly cash flow from investing activities?
- What is the all time high quarterly CFI for PTC Therapeutics?
- What is PTC Therapeutics quarterly CFI year-on-year change?
- What is PTC Therapeutics TTM cash flow from investing activities?
- What is the all time high TTM CFI for PTC Therapeutics?
- What is PTC Therapeutics TTM CFI year-on-year change?
What is PTC Therapeutics annual cash flow from investing activities?
The current annual CFI of PTCT is $44.18 M
What is the all time high annual CFI for PTC Therapeutics?
PTC Therapeutics all-time high annual cash flow from investing activities is $290.18 M
What is PTC Therapeutics annual CFI year-on-year change?
Over the past year, PTCT annual cash flow from investing activities has changed by +$220.92 M (+125.00%)
What is PTC Therapeutics quarterly cash flow from investing activities?
The current quarterly CFI of PTCT is $267.71 M
What is the all time high quarterly CFI for PTC Therapeutics?
PTC Therapeutics all-time high quarterly cash flow from investing activities is $267.71 M
What is PTC Therapeutics quarterly CFI year-on-year change?
Over the past year, PTCT quarterly cash flow from investing activities has changed by +$382.64 M (+332.93%)
What is PTC Therapeutics TTM cash flow from investing activities?
The current TTM CFI of PTCT is $44.18 M
What is the all time high TTM CFI for PTC Therapeutics?
PTC Therapeutics all-time high TTM cash flow from investing activities is $326.02 M
What is PTC Therapeutics TTM CFI year-on-year change?
Over the past year, PTCT TTM cash flow from investing activities has changed by +$306.88 M (+116.82%)